Inspire Investing, LLC Neurocrine Biosciences Inc Transaction History

Inspire Investing, LLC

  • $959 Million
  • Q3 2024

A detailed history of Inspire Investing, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Inspire Investing, LLC holds 2,469 shares of NBIX stock, worth $308,625. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,469
Previous 4,523 45.41%
Holding current value
$308,625
Previous $622,000 54.34%
% of portfolio
0.03%
Previous 0.07%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024
SELL
$114.58 - $153.15 $235,347 - $314,570
-2,054 Reduced 45.41%
2,469 $284,000
Q2 2024

Aug 12, 2024
SELL
$130.86 - $143.19 $1.02 Million - $1.11 Million
-7,773 Reduced 63.22%
4,523 $622,000
Q1 2024

May 07, 2024
BUY
$130.4 - $143.74 $788,268 - $868,908
6,045 Added 96.7%
12,296 $1.7 Million
Q4 2023

Feb 12, 2024
SELL
$106.07 - $132.76 $556,549 - $696,591
-5,247 Reduced 45.63%
6,251 $823,000
Q3 2023

Oct 26, 2023
SELL
$94.02 - $117.1 $989,654 - $1.23 Million
-10,526 Reduced 47.79%
11,498 $1.29 Million
Q2 2023

Jul 31, 2023
BUY
$89.53 - $104.87 $115,225 - $134,967
1,287 Added 6.21%
22,024 $2.08 Million
Q1 2023

Apr 24, 2023
BUY
$94.11 - $123.02 $497,089 - $649,791
5,282 Added 34.18%
20,737 $2.1 Million
Q4 2022

Jan 26, 2023
BUY
$106.72 - $127.06 $1.44 Million - $1.72 Million
13,506 Added 692.97%
15,455 $0
Q3 2022

Nov 07, 2022
BUY
$92.03 - $107.81 $179,366 - $210,121
1,949 New
1,949 $207,000
Q2 2020

Aug 12, 2020
SELL
$85.09 - $130.36 $6,466 - $9,907
-76 Closed
0 $0
Q1 2020

May 08, 2020
BUY
$75.11 - $113.76 $5,708 - $8,645
76 New
76 $7,000
Q1 2018

Apr 13, 2018
SELL
$75.88 - $92.43 $531 - $647
-7 Closed
0 $0
Q4 2017

Feb 15, 2018
BUY
$58.53 - $77.59 $409 - $543
7
7 $1,000

Others Institutions Holding NBIX

# of Institutions
625
Shares Held
94.2M
Call Options Held
632K
Put Options Held
621K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Inspire Investing, LLC Portfolio

Follow Inspire Investing, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspire Investing, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email